Anne C. Spaulding, MD, MPH; Cindy M. Weinbaum, MD, MPH; Daryl T.-Y. Lau, MD, MPH; Richard Sterling, MD; Leonard B. Seeff, MD; Harold S. Margolis, MD; Jay H. Hoofnagle, MD
The prevalence of chronic hepatitis C virus (HCV) infection in prisons ranges from 12% to 31%. There are generally acceptedâ€”albeit still evolvingâ€”guidelines for identification and treatment of hepatitis C in the community. However, there is less agreement among health professionals caring for prisoners about best practices for identification, medical management, and treatment of hepatitis C. Inmates often lack health care before incarceration. In prisons, infected persons could be identified and the management of infection initiated; however, the high prevalence of HCV infection among prisoners would impose a disproportionate cost for hepatitis C care on the correctional system. The optimal solution is for prison and public health systems in the United States to jointly provide targeted HCV testing and standard-of-care hepatitis C medical management, treatment, and prevention programs to prison inmate populations. The authors report on a January 2003 meeting of experts in prison health, public health, hepatology, and infectious diseases and explore the clinical care, prevention, and collaboration needed to provide hepatitis C management in prisoners.
Learn more about subscription options.
Register Now for a free account.
Spaulding AC, Weinbaum CM, Lau DT, Sterling R, Seeff LB, Margolis HS, et al. A Framework for Management of Hepatitis C in Prisons. Ann Intern Med. 2006;144:762-769. doi: 10.7326/0003-4819-144-10-200605160-00010
Download citation file:
Published: Ann Intern Med. 2006;144(10):762-769.
Gastroenterology/Hepatology, Infectious Disease, Liver Disease, Prevention/Screening.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only